How should hearing problems be evaluated and managed in a pregnant patient?

Hearing Problems in Pregnancy

Pregnant patients with hearing problems require immediate audiometric evaluation to distinguish between pregnancy-related transient changes and pathological hearing loss requiring intervention, with management prioritizing safe treatments that protect both maternal hearing and fetal wellbeing.

Initial Evaluation Approach

When a pregnant patient presents with hearing concerns, the evaluation must differentiate between benign pregnancy-related changes and conditions requiring urgent treatment:

Key Clinical Features to Assess

Timing and Pattern:

• Sudden onset (within 72 hours) suggests sudden sensorineural hearing loss (SSNHL), which occurs most commonly in the third trimester or postpartum period 1, 2
• Gradual, bilateral, low-frequency changes suggest physiological pregnancy-related hearing alterations that typically resolve postpartum 3

Associated Symptoms:

• Tinnitus (present in 70% of pregnancy-related SSNHL cases) 1
• Aural fullness, vertigo, or dizziness suggest inner ear involvement 3
• Conductive symptoms with middle ear effusion may indicate preeclampsia-related fluid dysregulation 4

Pregnancy Complications:

• Pre-pregnancy obesity and elevated blood pressure are risk factors for SSNHL 2
• Preeclampsia with proteinuria can cause transient conductive hearing loss via secretory otitis media 4

Mandatory Objective Testing

Never rely on patient self-report alone - comprehensive audiometric evaluation is essential 5:

• Pure tone audiometry to quantify hearing thresholds and identify air-bone gaps
• Acoustic immittance audiometry (tympanometry) to distinguish conductive from sensorineural loss
• Speech recognition testing to assess functional hearing ability

Management Based on Diagnosis

For Sudden Sensorineural Hearing Loss (SSNHL)

SSNHL during pregnancy presents with severe hearing loss (mean initial threshold 63.4 dB), most commonly with flat or profound audiogram configurations 1.

Treatment Protocol:

1. First-line therapy: Combined oral and intratympanic corticosteroids

   • This approach is safe and effective for pregnant patients 6
   • Intratympanic steroid injection significantly improves outcomes (27.1 dB improvement vs. 15.7 dB without, p=0.042) 1
   • Overall recovery rate of 60% (33.3% complete, 26.7% partial) 1

2. Adjunctive therapy: Dextran-40

   • Safe during pregnancy and may enhance hearing recovery when combined with steroids 1, 2

3. Timing considerations:

   • Treatment should be initiated as soon as possible after diagnosis
   • Postpartum treatment remains effective for cases diagnosed late in pregnancy 7
   • Some patients show spontaneous improvement during follow-up 7

Critical Point: Pregnant patients with SSNHL have better prognosis than non-pregnant patients with similar clinical characteristics, though initial hearing loss is often more severe 7, 6.

For Preeclampsia-Related Conductive Hearing Loss

When otoscopy reveals bilateral middle ear effusion with B-type tympanograms in a preeclamptic patient 4:

1. Exclude alternative causes:

   • Upper respiratory infection (check inflammatory markers)
   • Barotrauma or tympanic membrane pathology (via otoscopy)
   • Rule out sensorineural component (bone conduction thresholds should be normal)

2. Management:

   • Combined diuretics (furosemide and spironolactone) for fluid overload reduction
   • This typically results in complete resolution within 3 days 4
   • Address underlying preeclampsia management

3. Delivery considerations:

   • May require expedited delivery if maternal condition deteriorates
   • Hearing typically resolves rapidly postpartum with appropriate fluid management 4

For Physiological Pregnancy-Related Hearing Changes

Mild, predominantly low-frequency hearing threshold elevations that are transient 3:

• Reassurance that these changes typically resolve after delivery
• No specific treatment required
• Follow-up audiometry postpartum to confirm resolution
• Document baseline for comparison if symptoms persist

Follow-Up and Rehabilitation

Audiometric Monitoring

All pregnant patients with hearing loss require follow-up audiometry 8:

• Initial follow-up: 1-2 weeks after treatment initiation for SSNHL
• Intermediate assessment: 2-3 months to evaluate treatment response
• Long-term monitoring: At least annually for adults with residual hearing loss 8
• More frequent monitoring warranted for fluctuating hearing loss

Rehabilitation for Residual Hearing Loss

Even with hearing improvement, patients may benefit from:

• Hearing aids or assistive listening devices for residual deficits 8
• Tinnitus management if persistent and bothersome
• Auditory rehabilitation to optimize communication function
• Genetic counseling if congenital hearing loss is suspected (25% recurrence risk for autosomal recessive cases) 9

Critical Pitfalls to Avoid

1. Do not delay audiometric testing - patient self-report is unreliable for determining severity and type of hearing loss 5

2. Do not assume pregnancy increases SSNHL risk - current evidence shows lower prevalence in pregnant vs. non-pregnant patients 2, but cases that occur require prompt treatment

3. Do not withhold corticosteroid treatment due to pregnancy concerns - oral and intratympanic steroids are safe and effective 6, 1

4. Do not dismiss conductive hearing loss in preeclamptic patients - this may indicate severe fluid dysregulation requiring urgent management 4

5. Do not skip postpartum follow-up - some patients show delayed recovery months after delivery, and postpartum treatment remains effective 7

6. Do not overlook inflammatory and coagulation markers - these pathways may affect hearing through metabolic mechanisms 7